FFTY vs. ARKG ETF Comparison

Comparison of Innovator IBD 50 Fund ETF (FFTY) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
FFTY

Innovator IBD 50 Fund ETF

FFTY Description

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD® 50 Index. It is actively managed. Under normal circumstances, the fund will invest in a portfolio of U.S.-listed, exchange-traded equities. FFTY picks 50 leading growth companies that trade on US exchanges, potentially including ADRs. After screening out securities with extreme recent price movements, the universe is ranked by a composite of 11 different fundamental and technical metrics. The top 50 stocks are weighted in tiers, with more weight given to higher-ranking companies. Components of the index are reviewed on a weekly basis. Based on market-wide technical signals, FFTY may substitute half of its equity portfolio with Treasury bills. The index will remain half equity, half T-bills until a reversal signal occurs. Its worth noting that the funds high-turnover strategy could lead to poor tracking and/or taxable capital gains payouts.

Grade (RS Rating)

Last Trade

$30.96

Average Daily Volume

79,149

Number of Holdings *

50

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.83

Average Daily Volume

2,221,130

Number of Holdings *

34

* may have additional holdings in another (foreign) market
Performance
Period FFTY ARKG
30 Days 14.45% 1.19%
60 Days 14.88% -6.00%
90 Days 17.01% -11.64%
12 Months 37.94% -13.66%
1 Overlapping Holdings
Symbol Grade Weight in FFTY Weight in ARKG Overlap
NTRA B 3.05% 3.82% 3.05%
FFTY Overweight 49 Positions Relative to ARKG
Symbol Grade Weight
HIMS B 3.77%
POWL C 3.6%
NVDA C 3.59%
VRT B 3.58%
STRL B 3.57%
FIX A 3.52%
PLTR B 3.47%
ATAT C 3.46%
DOCS C 3.28%
ARM D 3.22%
CLS B 3.21%
YOU D 3.09%
BWIN D 3.0%
ANET C 3.0%
EME C 2.99%
HROW D 2.95%
DUOL A 2.92%
BGNE D 2.79%
ADMA B 2.77%
IOT A 2.07%
MNDY C 2.05%
CWAN B 2.03%
RCL A 2.01%
FTAI B 2.01%
RYAN B 1.99%
LNTH D 1.99%
IBKR A 1.99%
AXON A 1.99%
ONON A 1.92%
AFRM B 1.12%
TT A 1.0%
MELI D 1.0%
VITL D 0.99%
TW A 0.99%
NOW A 0.99%
FOUR B 0.99%
TVTX B 0.98%
HWM A 0.97%
NFLX A 0.96%
PACS F 0.51%
KVYO C 0.51%
FTNT C 0.51%
ALNY D 0.51%
AGX B 0.5%
DY D 0.49%
DECK A 0.49%
AMSC B 0.49%
TOST B 0.48%
ZETA D 0.46%
FFTY Underweight 33 Positions Relative to ARKG
Symbol Grade Weight
TWST D -8.37%
RXRX F -7.42%
CRSP D -7.34%
ADPT C -5.03%
CDNA D -4.77%
VCYT B -4.51%
SDGR C -4.14%
BEAM D -4.01%
NTLA F -3.89%
IONS F -3.85%
NRIX D -3.78%
TXG F -3.56%
GH B -3.49%
ARCT F -3.19%
PSNL D -2.7%
ABSI F -2.19%
PACB F -2.16%
BFLY B -1.71%
VEEV C -1.7%
AMGN D -1.68%
ACCD D -1.47%
VRTX F -1.29%
ILMN D -1.25%
CERS C -1.18%
INCY C -1.11%
REGN F -0.92%
PRME F -0.9%
CMPS F -0.75%
MASS F -0.69%
QSI C -0.68%
EXAS D -0.65%
RPTX F -0.64%
MRNA F -0.01%
Compare ETFs